SCHEMBL29210489

SCHEMBL29210489

CC(=O)c1cccc(C2=CCN(C(=O)O)C(C(C)(C)C)C2)c1O

nearest known ligand 0.36

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 2/20 0.36
HNF4A P41235 1/20 0.32
PDK4 Q16654 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4150760 0.76 RBP4 (0.38)
SCHEMBL30259509 0.72 PDK4 (0.35) PDK4
SCHEMBL30259104 0.70 PDK4 (0.63) PDK4
SCHEMBL10475874 0.69 GRM1 (0.35)
SCHEMBL25267139 0.65 POLB (0.34)
SCHEMBL2827858 0.64 HNF4A (0.72) HNF4A
SCHEMBL755868 0.64
SCHEMBL25279603 0.63 CHRM5 (0.34)
SCHEMBL2327343 0.63 RBP4 (0.37) DRD2
SCHEMBL7301332 0.62 THRB (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4660194-A1 SALT AND CRYSTAL FORM OF CYCLOALKENE COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF Jiangsu Hansoh Pharmaceutical Group Co., Ltd. (CN) 2025-12-10 EP disclosed
WO-2024160271-A1 SALT AND CRYSTAL FORM OF CYCLOALKENE COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF 江苏豪森药业集团有限公司 2024-08-08 WO disclosed
CN-117986264-A Benzo nitrogen-containing polycyclic derivative regulator and preparation method and application thereof 江苏豪森药业集团有限公司 2024-05-07 CN disclosed
CN-117751110-A Cycloolefin derivative regulator, preparation method and application thereof 上海翰森生物医药科技有限公司 2024-03-22 CN disclosed
WO-2023011539-A1 CYCLOALKENE DERIVATIVE REGULATOR, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF 上海翰森生物医药科技有限公司 2023-02-09 WO disclosed